• 2015

Company Description

Metacrine is a privately held biotech company 


Metacrine is a privately held biotech company 
founded in 2015 on technology licensed from the 
laboratory of Dr. Ronald Evans, a world leader in
 nuclear hormone receptors and Howard Hughes
Medical Institute Investigator at the Salk Institute. Metacrine will leverage two mechanistically distinct programs to target diabetes, steatohepatitis and other metabolic and liver disorders.